Biologics in Asthma

IF 2.7 3区 医学 Q2 ALLERGY Immunology and Allergy Clinics of North America Pub Date : 2024-09-06 DOI:10.1016/j.iac.2024.08.004
{"title":"Biologics in Asthma","authors":"","doi":"10.1016/j.iac.2024.08.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":54997,"journal":{"name":"Immunology and Allergy Clinics of North America","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology and Allergy Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889856124000614","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生物制剂治疗哮喘:实现临床缓解的潜力。
确定哮喘缓解的通用定义有可能改善哮喘的治疗效果并推动研究。然而,尽管多学科为实现这一目标做出了广泛的努力,但目前仍没有达成共识的定义。本研究探讨了哮喘缓解这一不断演变的概念,强调了生物制剂实现这一状态的潜力。我们将讨论各种拟议的哮喘缓解定义、国际指南以及评估生物制剂实现临床缓解效果的研究。我们强调有必要就哮喘缓解的定义达成共识,以统一治疗目标并改善患者预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.40
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: Immunology and Allergy Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in immunology and allergy and is presented under the direction of an experienced guest editor. Topics include allergens, immunotherapy, anaphylaxis, asthma, drug allergy, eosinophilrelated disorders, food allergy, immunodeficiency states (non-HIV), basic science, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema. Immunology and Allergy Clinics of North America is published four times each year, in February, May, August, and November.
期刊最新文献
Contents Asthma Biologics Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma Biologics in Allergic/Immunologic Conditions Copyright
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1